Aurora Italia
About Aurora Italia
Italian arm of Aurora Cannabis supplying pharmaceutical-grade medical cannabis to the Italian market through authorised distribution channels.
Key Facts
- 1Parent company Aurora Cannabis is one of Canada's largest licensed producers
- 2Supplies Italian pharmacies via partnerships with local pharmaceutical distributors
Latest News
Aurora Cannabis Trades at Deep Discount Despite Operational Headwinds
ACB shares present compelling value opportunity as market overreacts to near-term challenges while fundamentals show stabilization potential.
Aurora Cannabis Q4 Earnings: Revenue Decline Signals Continued Struggles
Aurora Cannabis reports disappointing Q4 2026 results with revenue dropping amid intensifying competition and operational challenges in key markets.
Aurora Cannabis CEO Champions Canadian Medical Cannabis Quality Edge
ACB leadership highlights competitive advantages in global medical cannabis market as company positions for international expansion opportunities.
Aurora Cannabis Beats Q4 Revenue Expectations as Turnaround Gains Traction
ACB delivers stronger-than-expected quarterly revenue, signaling potential stabilization after years of operational challenges and market volatility.
Aurora Cannabis Posts Record Revenue as Turnaround Strategy Takes Hold
Aurora Cannabis delivers record annual revenue and positive adjusted EBITDA, marking a pivotal turnaround for the embattled Canadian cannabis giant.
Frequently Asked Questions
What products does Aurora supply in Italy?
GMP-certified dried cannabis flower and standardised cannabis oil preparations for medical use.
Is a prescription required?
Yes, all Aurora Italia products require a physician's prescription and are dispensed only through pharmacies.
More Cannabis Companies in Milan
Cannabis Laws
Products
- Medical cannabis flower
- Standardised cannabis oils
Specialties
Company Details
- Type
- Medical & Pharma
- Location
- Milan, Italy
- Founded
- 2019
- Publicly Traded
- Yes
- Ticker
- TSX:ACB